Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
(OTCMKTS:EAPH) Looks Ahead to a Busy Month
By Jermaine Farmer - Orical report
FacebookTwitter
Easton Pharmaceuticals Inc (OTCMKTS:EAPH) is a micro-ca biopharma player that has increasingly captured the attention of the OTC trading crowd. Based on a little digging into recent press releases, it’s clear there are some important announcements on the way, including a couple potential key acquisitions. In addition, the company just announced after having received initial payment towards product purchase order from pharmaceutical multi-national Gedeon Richter’s Plc subsidiary – Gedeon Richter Mexico S.A.P.I. de C.V., the first shipment of “Gynofit” bacterial vaginosis treatment has been shipped and received in Mexico in preparation of its product launch in Puerto Vallarta, Mexico for February 16th.
According to the company’s recent release, Gedeon Richter will be showcasing the products as it launches its marketing and sales program with a steadily increasing marketing budget over the next 3 years. Easton / BMV will provide sales figures and projections sometime in the next quarter.
Easton Pharmaceuticals Inc (OTCMKTS:EAPH) frames itself as a specialty pharmaceutical company, designs, develops, and markets various topically-delivered drugs and therapeutic health care products.
Its products include Nauseasol, a motion sickness gel; Skin Renou HA, an anti-aging wrinkle cream using hyaluronic acid, which keeps the skin smooth; Kenestrin Gel used for arthritis, knees, elbows, shoulders, wrist, and back pain; Viorra, a hormone free, non-toxic, and topical gel that improves sexual functioning of women; and female sexual arousal disorder drug.
The company is also developing XILIVE, an early stage cancer drug. In addition, it is involved in the medical marijuana business. The company was formerly known as LAM Industries, Inc. and changed its name to Easton Pharmaceuticals Inc. in March 2010. Easton Pharmaceuticals Inc. was founded in 1997 and is based in Toronto, Canada.
According to company materials, “Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries. The Company previously developed and owned an FDA-approved wound-healing medical device and currently owns topically delivered drugs to treat cancer and other therapeutic products to treat various conditions that are all in various stages of development and approval. Easton has partnered with BMV Medica and together, own the exclusive distribution rights in Mexico and Latin America for patented women’s diagnostic and preventative care products, along with two generic cancer drugs Paclitaxel and Docetaxel.”
Find out when $EAPH stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
big.chart (579×335)
As the company communicates, “Gynofit” is a natural product treatment for women diagnosed with BV (Bacterial Vaginosis), a condition that affects nearly all women at some point in their lives and is one of the most common reasons for gynecological visits by women. In addition, Gynofit will be promoted for help in maintenance of a healthy vaginal flora. As previously announced, the agreement with Gedeon Richter Mexico S.A.P.I de C.V. provides for annual minimums in return for granting exclusivity. Gedeon Richter Plc and Gedeon Richter Mexico S.A.P.I. de C.V. has committed to a strong marketing plan for Gynofit and its success, which Easton / BMV and Gedeon Richter believe will steadily drive sales in Mexico over the next three years and beyond.
According to the company’s recent release, management notes that they continue to move forward with due diligence for the acquisition of revenue generating iBliss Inc., as previously announced, and expect to have the transaction completed sometime in the month of February once all terms of the agreement have been agreed to and finalized.
Traders take note: that’s a relatively blatant statement about an upcoming catalyst.
In fact, it gets better: the company goes on to state that “Easton is also confirming that it has entered into negotiations towards acquiring a second revenue generating company possessing strong international sales which could coincide with the closing of iBliss and BMV Medica S.A. Easton is also in late stage negotiations towards 2 (two) agreements with two 2 (two) medical marijuana companies, one in Jamaica and the other in the US, both expecting to potentially add significant and near term sales to Easton. Updates are expected this month or as they materialize.”
Recent action has seen 55% during the past month in terms of shareholder gains in the company. In addition, the listing has seen interest climb, with an increase in recent trading volume of exceeding 210% over the long run average. Since we last covered the name, the stock has moved 31% higher.
Currently trading at a market capitalization of $40.1M, EAPH has virtually no cash on the books, which is balanced by about $115K in total current liabilities. One should also note that debt has been growing over recent quarters. The company is pre-revenue at this point. As more color becomes clear on the name, we will review the situation and update our take. For continuing coverage on shares of $EAPH stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!
Sign Up for our 100% FREE Oracle Dispatch Newsletter
Submit
TAGSBIOPHARMAEAPHPHARMACEUTICALSTOPICALLY
FacebookTwitter
Previous article
A Closer Look at Eco Science Solutions Inc (OTCMKTS:ESSI)
Next article
New Partnership Potential Stirs Earth Science Tech Inc (OTCMKTS:ETST)
RELATED ARTICLESMORE FROM AUTHOR
ERBB stock
American Green Inc (OTCMKTS:ERBB) Garners Attention with New App
BNTC
Benitec Biopharma Ltd (ADR) (NASDAQ:BNTC) Moving After Key Update
Silvercorp Metals
Silvercorp Metals Inc (OTCMKTS:SVMLF) Delivers the Goods
LEAVE A REPLY
POPULAR POSTS
NAKD Stock
Naked Brand Group Inc (NASDAQ:NAKD) Launches in Reaction to Product Launch
February 6, 2017
ERBB stock
American Green Inc (OTCMKTS:ERBB) Garners Attention with New App
February 6, 2017
NEWC stock
New Colombia Resources Inc (OTCMKTS:NEWC) Planting the Seeds
February 6, 2017
BNTC
Benitec Biopharma Ltd (ADR) (NASDAQ:BNTC) Moving After Key Update
February 6, 2017
AZFL
AMAZONAS FLORESTAL COM USD0.001 (OTCMKTS:AZFL) Getting on Track
February 6, 2017
Silvercorp Metals
Silvercorp Metals Inc (OTCMKTS:SVMLF) Delivers the Goods
February 5, 2017
ETST
New Partnership Potential Stirs Earth Science Tech Inc (OTCMKTS:ETST)
February 5, 2017
Easton Pharmaceuticals Inc
Easton Pharmaceuticals Inc (OTCMKTS:EAPH) Looks Ahead to a Busy Month
February 5, 2017
Eco Science
A Closer Look at Eco Science Solutions Inc (OTCMKTS:ESSI)
February 5, 2017
CIIX stock
ChineseInvestors.com Inc (OTCMKTS:CIIX) Pulls Back in Red Hot Trend
February 4, 2017
OracleDispatch.com
Welcome to the Oracle Dispatch, a free online newspaper packed with exclusive content, news, articles and much more! Each day you’ll receive the latest business and industry news, financial analysis and much more. All this, and it’s free. Join the thousands of Oracle Dispatch users who are already with us! If you have any questions please visit contacts page.
EVEN MORE NEWS
NAKD Stock
Naked Brand Group Inc (NASDAQ:NAKD) Launches in Reaction to Product Launch
February 6, 2017
ERBB stock
American Green Inc (OTCMKTS:ERBB) Garners Attention with New App
February 6, 2017
NEWC stock
New Colombia Resources Inc (OTCMKTS:NEWC) Planting the Seeds
February 6, 2017
POPULAR CATEGORY
Investing
Opinion
Wall Street Daily
Sector News
© Copyright 2016 - Oracle Dispatch. All Rights Reserved
Sign up for our 100% FREE Oracle Dispatch Newsletter
SUBSCRIBE NOW!
2 to 5 cents by the summer would be awesome. Holding almost 22 million.
Yap I see that friend... Well well.
When EAPH gets all their deals finalized, 25 cents is on the way a
10 cent for amfe. Imho
Actually is was $4 at on time.
I am a EAPH share holder from way back. I understand Eaph and AMFE will be working together soon. I am looking to buy a few of your shares.
I am not selling for less than 50 cents or more.
Great things happen for those that wait and believe. I am in, what will we hit this week? 6 cents??
Trust me everyone in this business is buying into Usmj... Future deals are in the works for more partner ships... Usmj is a win win for everyone in the business.. It's a big deal and I see the big picture. 30 cents this year is not impossible.
ONE of these days it's going to run run run !!!
Friends: the next 6 month will be life changing for long term holders.
Lexus4000: by the way at 5 cents I can retire and buy me a new Lexus.
Sold out months ago but I I felt an urgency to buy back in, I just feel this ship is about to take off... Holding a small amount of 5.2 mill.. But if it goes back to 10 cents I can retire.
Sold out a while back, working on buying back in, 5 mill for 0016.
Any night owls still up.. anticipation...:)
I am looking into this stock .. What do they do?
Vince ---> very well said. Thank you sir.
Sillywilly --> I recieve that..:)
Mck; have a blessed and safe trip my friend. I am fairly new to the page but I see that you bring a lot of life with your informative style. Thank you sir ....3.2 million strong, I am looking for that 50 cents.. So I will have the funding to facilitate my dream.
Fabulous: tomorrow should be good and all next week.
Is there a real tweet from EAPH about a news release coming out tomorrow??
Or is it hear say?
Thanks bro. Powerful and true. A great word, if u know what I mean!!!!
Marijuana Industry Pushing Toward Federal Acceptance, Expanded Research in 2017
NEWS
NEW YORK, February 1, 2017 /PRNewswire/ --
NetworkNewsWire News Coverage: For the marijuana industry, 2016 was a successful year by any standards, reaching an estimated $7 billion in transactions and bringing the total number of states to legalize marijuana for medical and/or recreational purposes to 28. However, deemed America's fastest growing industry in recent years, the market still has some major obstacles to overcome in 2017, such as gaining access to legal banking services, obtaining federal drug reclassification, and more. Removing marijuana from the federal list of Schedule I drugs would be a major step forward for the industry, with massive implications and benefits trickling through to reach cannabis-related product manufacturers and distributors and ancillary service providers such as Cannabis Sativa, Inc. (OTCQB: CBDS), Cannabis Science, Inc. (OTC: CBIS), Eco Science Solutions, Inc. (OTC: ESSI), Medical Marijuana, Inc. (OTC: MJNA), and SinglePoint, Inc. (OTC: SING)
According to Cannabiz Media research firm, the industry headed into 2017 with over 4,300 cultivators, more than 2,500 producers, 3,300 dispensaries and almost 4,000 retailers nationwide. The numbers are expected to grow significantly in light of the recent vote by eight more states to legalize medical or recreational marijuana use. Driven by this impressive growth, the industry will look to make a bigger impact this year, primarily by gaining federal acceptance. The industry is already lobbying in favor of removing marijuana from the list of Schedule I drugs, where it is currently listed alongside heroin, ecstasy and LSD. It may take as long as four to eight years to gain federal acceptance, experts say, but the tide is in favor of the industry and, ultimately, the administration will likely adhere to the wishes of the American majority.
There are concerns that under the Trump Administration, and especially with marijuana opponent U.S. Senator Jeff Sessions (R-AL) as attorney general, the industry will struggle more and might lose rights gained at a state level. President Donald Trump, who spoke in favor of the marijuana market during the campaign, has yet to make his official position known. In the meantime, a group of 10 prominent lawmakers are pressing for banking reform to allow cannabis and related businesses access to financial services. In an open letter, the lawmakers asked the Financial Crimes Enforcement Network to issue clear guidance on the matter in order to make it easier for the industry to access banking services.
New to iHub - The Cannabis Report - Click Here
EAPH--> I believe in the medical side of this.. Help comes in many forms. A human being gets an idea one day, then they work hard at it for years, getting criticized by lesser minded people with no ambition of their own. Until one day all the hard work comes to fruition and hence they promoted what was once just an idea into Reality and perhaps developed something that will change the course of a sector forever. Maybe even going as far as helping the health of millions upon millions of people. Now that's a game changer, something way bigger than a stock price could ever show.
Congratulations everyone.. I am seeing some 30,000 to 40,000 dollar days. Wife is happy, not the mention myself:)
Is this what you heard?
BARRONS REPORT--->
The price-to-book ratio (P/B Ratio) is a ratio used to compare a stock's market value to its book value, and BARRONS has it rated @ 2.70 on there website!!!
After sillywillys report he posted ... I am not selling until we reach $1.50
5's by noon today!!!
EAPH IS GOLDEN,,,SOON The flood gates are open in 2017. Net up will be Big MMJ news. There are 2 - 4 MMJ deals in the works with EAPH. This will be a PPS driving force to get EAPH around .08. Add the 98% possibility of Bayer being the additional JV Partner for Approved Women's Health Products in Mexico. Add the purchase of BMV Assets and EAPH will be over .10..........Incoming revenues bring EAPH up to .25 or higher. EAPH is golden.
WHAT iS HAPPENING now and what is going to happen in the near future. Right now the companies that USMJ are making deals with including insiders, families and friends are buying up 100's of millions of shares.With them knowing what's about to happen they are holding long term. The only people that are going to sell in the short term are the people that are convinced it's a pump and dump. These folks will sell out at 1 to 3 cents. Insiders will not sell themselves short. They will hold out for 50 cents or more. So imho this will go up fast .. Like in 3 months it could reach the 50 cent level. Imho
Thanx mck; did you recieve this tonight ?
It's starting to feel like this could run to 50 cents in the short term ... Like 2 months. Exciting times ahead. I know money can't buy happiness but it sure helps makes the journey of life easier. ps. I am also a big holder of USMJ. Both look good.
Lol... Can wait to watch this move one to two pennies a day ... Wow... Thanks, been following you a while, I am about to have more time doing what I want to do and that is make music and make the world a better place to live.
5 cents ??
I hope I am not greedy but I will not think of selling until possibly /25 cents
I can see that 15 to 20 cents will be very conservative.
Loading another million today.
Kramer indicating it could go past 1 penny. :) in article
Closing out strong.